The target of the t-PA released from the hydrogel is the nascent clot, i.e. initially formed fibrin. Thus, a fibrinogen–thrombin clot assay47 was used to investigate the fibrinolytic activity of the releasate. Briefly, the t-PA-loaded hydrogels were incubated in plasminogen solution in the presence/absence of thrombin. (Plasminogen is activated by t-PA and transformed into plasmin, its fibrinolytically-activeform.)Fibrinogen solution, whichinthe presence of thrombin produces fibrin, was then added. The absorbance of the solutions at 340 nm was then measured over time. For the hydrogel incubated in buffer only (no thrombin), thrombin was added immediately before the absorbance measurements. As seen in Fig. 4a, thrombin-initiated clot formation in the fibrinogen solution is indicated by a steep increase in absorbance. For the releasate from the hydrogel incubated in PBS (no thrombin), a plateau in absorbance was reached after a few minutes, indicating a fully formed, stable clot. In contrast, the releasate from the hydrogel incubated in thrombinsolutionshowedaninitialabsorbanceincreasefollowed by a return to the baseline within 30 min, indicating that clotting was initiated and the nascent clot then lysed. A similar high turbidity was observed at 2 min for both samples, whereas the releasate from the hydrogel incubated in thrombin solution was clear at the end of the assay. It may be concluded that t-PA released from the hydrogel in response to thrombin converted plasminogen to plasmin in the solution, leading to clot lysis.
The target of the t-PA released from the hydrogel is the nascent clot, i.e. initially formed fibrin. Thus, a fibrinogen–thrombin clot assay47 was used to investigate the fibrinolytic activity of <br>the releasate. Briefly, the t-PA-loaded hydrogels were incubated in plasminogen solution in the presence/absence of thrombin. (Plasminogen is activated by t-PA and transformed into plasmin, its fibrinolytically-activeform.)Fibrinogen solution, whichinthe presence of thrombin produces fibrin, was then added. The absorbance of the solutions at 340 nm was then measured over time. For the hydrogel incubated in buffer only (no thrombin), thrombin was added immediately before the absorbance measurements. As seen in Fig. 4a, thrombin-initiated clot formation in the fibrinogen solution is indicated by a steep increase in absorbance. For the releasate from the hydrogel incubated in PBS (no thrombin), a plateau in absorbance was reached after a few minutes, indicating a fully formed, stable clot. In contrast, the releasate from the hydrogel incubated in thrombinsolutionshowedaninitialabsorbanceincreasefollowed by a return to the baseline within 30 min, indicating that clotting was initiated and the nascent clot then lysed. A similar high turbidity was observed at 2 min for both samples, whereas the releasate from the hydrogel incubated in thrombin solution was clear at the end of the assay. It may be concluded that t-PA released from the hydrogel in response to thrombin converted plasminogen to plasmin in the solution, leading to clot lysis.
正在翻译中..